These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19958754)

  • 1. Stabilization of human urine doping control samples: III. Recombinant human erythropoietin.
    Tsivou M; Dimopoulou HA; Leontiou IP; Georgakopoulos DG; Koupparis MA; Atta-Politou J; Georgakopoulos CG
    Clin Chim Acta; 2010 Mar; 411(5-6):448-52. PubMed ID: 19958754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of human urine doping control samples: IV. Human chorionic gonadotropin.
    Tsivou M; Dimopoulou HA; Georgakopoulos DG; Koupparis MA; Atta-Politou J; Georgakopoulos CG
    Anal Bioanal Chem; 2010 Oct; 398(3):1313-8. PubMed ID: 20658279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of human urine doping control samples: II. microbial degradation of steroids.
    Tsivou M; Livadara D; Georgakopoulos DG; Koupparis MA; Atta-Politou J; Georgakopoulos CG
    Anal Biochem; 2009 May; 388(1):146-54. PubMed ID: 19232313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doping control container for urine stabilization: a pilot study.
    Tsivou M; Giannadaki E; Hooghe F; Roels K; Van Gansbeke W; Garribba F; Lyris E; Deventer K; Mazzarino M; Donati F; Georgakopoulos DG; Van Eenoo P; Georgakopoulos CG; de la Torre X; Botrè F
    Drug Test Anal; 2017 May; 9(5):699-712. PubMed ID: 27497113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin (EPO) immunoaffinity columns--a powerful tool for purifying EPO and its recombinant analogues.
    Dehnes Y; Lamon S; Lönnberg M
    J Pharm Biomed Anal; 2010 Dec; 53(4):1028-32. PubMed ID: 20656433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of human urine doping control samples: a current opinion.
    Tsivou M; Georgakopoulos DG; Dimopoulou HA; Koupparis MA; Atta-Politou J; Georgakopoulos CG
    Anal Bioanal Chem; 2011 Aug; 401(2):553-61. PubMed ID: 21499681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible origins of undetectable EPO in urine samples.
    Lamon S; Robinson N; Sottas PE; Henry H; Kamber M; Mangin P; Saugy M
    Clin Chim Acta; 2007 Oct; 385(1-2):61-6. PubMed ID: 17692836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing for recombinant erythropoietin.
    Delanghe JR; Bollen M; Beullens M
    Am J Hematol; 2008 Mar; 83(3):237-41. PubMed ID: 17918255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid affinity purification of erythropoietin from biological samples using disposable monoliths.
    Lönnberg M; Dehnes Y; Drevin M; Garle M; Lamon S; Leuenberger N; Quach T; Carlsson J
    J Chromatogr A; 2010 Nov; 1217(45):7031-7. PubMed ID: 20926083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of two immunoassays for the measurement of human chorionic gonadotropin in urine for anti-doping purposes.
    Robinson N; Sottas PE; Saugy M
    Clin Lab; 2010; 56(5-6):197-206. PubMed ID: 20575467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAIIA EPO SeLect-a rapid screening kit for the detection of recombinant EPO analogues in doping control: inter-laboratory prevalidation and normative study of athlete urine and plasma samples.
    Dehnes Y; Myrvold L; Ström H; Ericsson M; Hemmersbach P
    Drug Test Anal; 2014; 6(11-12):1144-50. PubMed ID: 25421537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone abuse in sports: the antidoping perspective.
    Barroso O; Mazzoni I; Rabin O
    Asian J Androl; 2008 May; 10(3):391-402. PubMed ID: 18385901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of immunoassays for the measurement of erythropoietin (EPO) as an indirect biomarker of recombinant human EPO misuse in sport.
    Abellan R; Ventura R; Pichini S; Remacha AF; Pascual JA; Pacifici R; Di Giovannandrea R; Zuccaro P; Segura J
    J Pharm Biomed Anal; 2004 Sep; 35(5):1169-77. PubMed ID: 15336362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin and analogs.
    Reichel C; Gmeiner G
    Handb Exp Pharmacol; 2010; (195):251-94. PubMed ID: 20020369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the instability of the isoelectric focusing patterns of erythropoietin in urine.
    Belalcazar V; Gutiérrez Gallego R; Llop E; Segura J; Pascual JA
    Electrophoresis; 2006 Nov; 27(22):4387-95. PubMed ID: 17054082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteases in doping control analysis.
    Thevis M; Maurer J; Kohler M; Geyer H; Schänzer W
    Int J Sports Med; 2007 Jul; 28(7):545-9. PubMed ID: 17525883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new analytical method based on anti-EPO monolith column and LC-FAIMS-MS/MS for the detection of rHuEPOs in horse plasma and urine samples.
    Bailly-Chouriberry L; Cormant F; Garcia P; Lönnberg M; Szwandt S; Bondesson U; Popot MA; Bonnaire Y
    Analyst; 2012 May; 137(10):2445-53. PubMed ID: 22454833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GASepo-a software solution for quantitative analysis of digital images in Epo doping control.
    Bajla I; Holländer I; Minichmayr M; Gmeiner G; Reichel Ch
    Comput Methods Programs Biomed; 2005 Dec; 80(3):246-70. PubMed ID: 16260062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels.
    Kohler M; Ayotte C; Desharnais P; Flenker U; Lüdke S; Thevis M; Völker-Schänzer E; Schänzer W
    Int J Sports Med; 2008 Jan; 29(1):1-6. PubMed ID: 18050057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of recombinant EPO in blood and urine samples with EPO WGA MAIIA, IEF and SAR-PAGE after microdose injections.
    Dehnes Y; Shalina A; Myrvold L
    Drug Test Anal; 2013; 5(11-12):861-9. PubMed ID: 24190107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.